Emcure Pharmaceuticals has acquired remaining 40,95,180 equity shares constituting 20.42% of Rs 10 each held by individual shareholders in Zuventus Healthcare (Zuventus). With this, Zuventus become a wholly owned subsidiary of the company. Zuventus is involved in the business of dealing in all types, descriptions, specifications, strengths and application of pharmaceutical medicaments in healthcare.
The existing equity shareholding of the company in Zuventus was 79.58%. Post-acquisition, the shareholding of the company in Zuventus is 100%.
Earlier, the board of directors of the company at its meeting held on June 21, 2025, had inter-alia approved the same.
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
